Vyvanse has been approved by the Food and Drug Administration to treat Attention Deficit Hyperactivity Disorder (ADHD) for children six years old to twelve years old. This medication has not been tested in children under the age of six and should not be given to children five and under.
Vyvanse is a short acting medication Normally, the first dose of Vyvanse is taken first thing in the morning. Additional doses can...
Read moreAn endoscopy is a procedure that allows a physician to see the inside of the esophagus and stomach. Until recently, this procedure involved... Read more »
My son Lawrence started kindergarten last year. It was kind of tough on him. The class was three hours long, and they only had a short, ten... Read more »
The effects of hormones and neutransmitters as they relate to mania and depression are extremely complex and far beyond the scope of a... Read more »
On March 10, 2011, King Pharmaceuticals, Inc., a subsidiary of Pfizer, Inc., voluntarily recalled all dosage forms of Embeda® (morphine... Read more »
Yesterday the U.S. Food and Drug Administration announced that it is asking manufacturers of prescription combination products that contain... Read more »
The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of... Read more »
Migraine prevention is one of the most important issues facing Migraineurs who experience frequent and / or debilitating Migraine attacks. The vast... Read more »
Source: ADAM Encyclopedia
Lifestyle Treatment and PreventionPeople with heartburn should first try lifestyle and dietary changes. Some suggestions are:Avoid or reduce... Read more »